BALCHEM CORP (BCPC)
Materials · Specialty Chemicals / Specialty Ingredients · NASDAQ
Balchem is a leading developer of specialty performance ingredients and solutions for the food, animal health, and pharmaceutical industries, with a strong focus on high-value microencapsulation and specialty chemical technologies.
What BALCHEM CORP does
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, pharmaceutical, animal health, and medical sterilization markets. The company operates through segments focused on human nutrition and health, animal nutrition and health, and specialty products, providing solutions such as microencapsulation, minerals, and gases.
Themes: nutritional science, food and beverage ingredients, animal nutrition, medical sterilization gases, health and wellness supplements, microencapsulation technology
Fundamentals
- Price$168.63 as of 2026-10-08 close
- Market cap$5.4B as of 2026-07-23 (share count; price 2026-10-08)
- 1-year return+18.4% 2025-10-08 close $142.44 → 2026-10-08 close $168.63
- P/E33.17 as of 2026-10-08
- Net margin+14.9% FY2025, SEC XBRL
- Gross margin+35.7% FY2025, SEC XBRL
- ROE+12.3% FY2025, SEC XBRL
- Debt / equity0.12 as of 2026-09-03
- Revenue growth (YoY)+10.1% as of 2026-09-03
- Revenue CAGR (3y)+3.2% SEC XBRL
- Beta0.47 as of 2026-09-03
- Last reported earnings2026-07-31 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +0.6%; at least 4 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How BCPC compares in its sector
- price-to-earnings ratiomiddle range 91 covered Materials peers, as of 2026-10-08
- net profit margintop 25% 125 covered Materials peers, as of 2026-09-03
- operating margintop 25% 108 covered Materials peers, as of 2026-09-03
- gross margintop 25% 92 covered Materials peers, as of 2026-09-03
- return on equitymiddle range 144 covered Materials peers, as of 2026-09-03
- 3-year revenue CAGRmiddle range 127 covered Materials peers
- indicated dividend yieldbottom 25% 95 covered Materials peers, as of 2026-09-03
Position among covered Materials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
BCPC is not currently in any published Top 10 list. Its scores are below.
Top 10 score
54.0 #521 of 1,379 scored · #18 of 73 in Materials
Financial health 64th (debt to equity 0.1, free cash flow margin 9.5%) and profitability 64th (operating margin 20.2%, return on equity 12.3%); weakest is valuation (34th, price to earnings 33.2, price to book 4.1).
Scores as of 8 Oct 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 4.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, BCPC's dividend was covered by reported results (earnings payout 18%, operating-cash-flow payout 13%). This describes past coverage, not a forecast.
- Earnings payout18% dividends / net income
- Operating-cash-flow payout13% dividends / operating cash flow — capital spending was not reported, so this does not subtract it
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How BALCHEM CORP looks technically
BALCHEM CORP (BCPC) is trading 0.3% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 48 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 15, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 51, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bullish about 2 trading days ago (its momentum flipped positive). It made a new 20-day low about 6 trading days ago. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 3% of the past ~6 months), which often precedes a bigger move.
Trend
9
| Distance from the 200-day | it is trading 0.3% above its 200-day average, the long-term trend line — a longer-term uptrend | +0.3% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $172.12 | $172.12 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $168.13 | $168.13 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing low 7 calendar days ago — the swings before that are what the structure reading is measured on | 7 sessions |
| Wave structure | its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five; the labelling fails if price closes below 161.05. It is one of several labellings that fit, and it describes the swings already printed, not what comes next. The same swings also read as a three-part correction in leg C. | possible upward five-wave sequence, in wave 3 (one of several readings) |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 48 trading days ago — a "golden cross", a bullish long-term signal | 48 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 0.3% above | +0.3% |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 15, below the 25 that marks a real trend) | 14.6 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 51, neither overbought (above 70) nor oversold (below 30) | 51.0 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($161.05 to $170.62) — its "stochastic" reading is 79 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 79.2 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bullish about 2 trading days ago (its momentum flipped positive) | 2 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $183.75 | $183.75 |
|---|---|---|
| From the 52-week high | it is 8.2% below its 52-week high (its highest price of the past year) | -8.2% |
| Above the 52-week low | it is 21.2% above its 52-week low (its lowest price of the past year) | +21.2% |
| Below the 52-week high | it is 8.2% below its highest point of the past year | 8.2% |
| Since a 20-day breakout | it made a new 20-day low about 6 trading days ago | 6 sessions |
| Since a 55-day breakout | it made a new 55-day high about 34 trading days ago | 34 sessions |
| All-time high | its highest closing price on record is $186.03 (set on 2024-07-29) | $186.03 |
| Given back of the 52-week move | over the past year its closes ranged ($140.30 to $183.26), and it has given back roughly a third of its rise from last year’s low — 34% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $155.34 to $156.71. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 34.0% |
| From the all-time high | it is 9.4% below its all-time high | -9.3% |
| Nearest price level | it is trading 0.7% below a resistance level at $169.73 — a price it turned at six times since 2025-04-02, most recently on 2026-09-22. Since 2024-10-08 it has 5 such levels below the current price and 3 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | +0.7% |
| All-time low | its lowest closing price on record is $7.58 (set on 2005-10-25) | $7.58 |
| Above the all-time low | it is 2124.9% above its all-time low | +2,125% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 3% of the past ~6 months), which often precedes a bigger move | 3rd percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $3.43 between its high and its low — about 2.0% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $3.43 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $163.87 and $169.53 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $163.87 – $166.70 – $169.53 |
| Typical daily range (% of price) | its price moves about 2.0% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.0% |
| Stretch from the 200-day average | it is trading 0.2 daily ranges above its 200-day average price (0.3% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 0.2 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.94× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | not available for this company yet | n/a |
Candlestick patterns
2
| Since a doji | 3 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 3 sessions ago |
|---|---|---|
| Since a bearish engulfing | 2 sessions ago it opened above the previous session's close and finished below that session's open — a "bearish engulfing" pair, where one down day more than undid the up day before it | 2 sessions ago |
Price gaps
1
| Gap at the open | it opened on 2026-10-08 0.1% above the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | +0.1% |
|---|
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +2.02% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock lagged the market by 2.2 percentage points (the stock lost 1.1% while the market gained 1.0%) | -2.2% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock lagged the market by 2.2 percentage points (the stock gained 1.6% while the market gained 3.8%) | -2.3% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 18.0 percentage points (the stock lost 0.6% while the market gained 17.5%) | -18.0% |
| vs market, 12 months | over the past 12 months this stock beat the market by 3.4 percentage points (the stock gained 18.4% while the market gained 15.0%) | +3.4% |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, MACD momentum is positive — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: lagging the market over 6 months, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 1.4% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-01 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 2.1% of the share price. | -1.4% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is sitting right on the average price paid so far this year, so the typical buyer over that stretch is roughly break-even. That average is $168.61 — a volume-weighted average of daily closes over 190 sessions, not a true tick-by-tick VWAP. | +0.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is 1% below the average price paid since it last reported on 2026-07-31 (its 10-Q), so the typical buyer over that stretch is under water. That average is $171.17 — a volume-weighted average of daily closes over 49 sessions, not a true tick-by-tick VWAP. | -1.5% |
Price levels it has turned at before
BCPC last closed at $168.63 on 2026-10-08. Since 2024-10-08 it has turned at 5 prices below its last close and 3 above; the 3 nearest below and the 3 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $169.73 | Resistance | 0.7% above the last close | turned there six times · 2025-04-02 to 2026-09-22 |
| $164.96 | Support | 2.2% below the last close | turned there 13 times · 2024-10-24 to 2026-09-15 |
| $175.55 | Resistance | 4.1% above the last close | turned there 7 times · 2024-10-16 to 2026-08-14 |
| $160.77 | Support | 4.7% below the last close | turned there 7 times · 2025-03-21 to 2026-10-01 |
| $157.60 | Support | 6.5% below the last close | turned there 7 times · 2025-02-12 to 2026-07-13 |
| $183.18 | Resistance | 8.6% above the last close | turned there six times · 2024-10-25 to 2026-08-24 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a five-part upward sequence — what Elliott-wave chartists call an impulse — now in leg 3 of five.
This labelling fails — stops being a possible reading at all — if it closes below $161.05.
This is one of several labellings that fit the same swings, so treat it as a reading rather than the reading. It was chosen from 2 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $183.84 and $197.93 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
Alternate reading: The same swings also read as a three-part correction in leg C, which fails on a close below $161.05.
This reading has stood for 5 trading days, since 2026-10-02.
Read from daily closes as of 2026-10-08.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Near 200-day moving-average support · Trading above the 200-day moving average · MACD just crossed bullish (12/26/9) · in a Bollinger Band volatility squeeze · trendless / choppy (low ADX) · lagging the market | Learn: moving average · golden cross · adx · rsi · macd · breakout · bollinger bands
Based on daily closing prices as of 2026-10-08. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Mean price target$209.25 range $165.00 – $242.00; median $215.00
Analyst estimates, as of 2026-10-06. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for BCPC
- Consensus EPS estimate$1.54 next reporting period, as of 2026-10-06
- Estimate change, 30 days$0.00 (0.0%) from $1.54, on 2026-09-01, 35-day window
- Readings revised upward0% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Exposure to fluctuations in raw material costs and availability.","Dependence on specialized manufacturing processes and complex supply chains.","Risks associated with international operations, including foreign currency volatility."]
What changed in the latest 10-Q
AI-assisted comparison of BCPC's 10-Q filed 2026-07-31 against the prior one filed 2026-04-30.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-07-31) states that as of June 2026, Balchem has participated in the IEEPA tariff refund process to the extent it was the importer of record and directly paid tariffs under IEEPA.
- Removed:
- Older filing (2026-04-30) states that the availability, timing, and amount of any potential refunds related to IEEPA tariffs remain highly uncertain and are subject to ongoing legal, regulatory, and administrative developments.
- Reworded:
- Employee count updated from approximately 1,368 full time employees as of March 31, 2026 (older filing, 2026-04-30) to approximately 1,379 full time employees as of June 30, 2026 (newer filing, 2026-07-31).
- Labor market description changed from 'We continue to see improvement in the labor markets and we feel that our team has been successful in attracting and retaining skilled and experienced employees in a competitive landscape' (older filing, 2026-04-30) to 'Labor market conditions remained generally stable during the quarter, supporting our ability to attract and retain skilled and experienced employees in a competitive talent market' (newer filing, 2026-07-31).
- Technology description changed from 'we continue to enhance and leverage our existing technology capabilities to further optimize productivity and performance, and explore new solutions to drive efficiencies' (older filing, 2026-04-30) to 'we continued to invest in and leverage technology solutions to enhance productivity, improve performance, and drive operational efficiencies across the organization' (newer filing, 2026-07-31).
- Geopolitical Conflicts heading content changed from 'We are monitoring the heightened geopolitical tensions' (older filing, 2026-04-30) to 'We continue to monitor the heightened geopolitical tensions' (newer filing, 2026-07-31).
- Tariff section heading changed from 'Supreme Court Tariff Ruling' (older filing, 2026-04-30) to 'Tariffs' (newer filing, 2026-07-31).
- Tariff section opening changed from 'In February 2026, the U.S. Supreme Court issued a ruling striking down certain tariffs previously imposed under the International Emergency Economic Powers Act ("IEEPA"). While the online portal...' (older filing, 2026-04-30) to 'We continue to monitor developments with respect to tariffs and other trade policy matters closely, including impacts from the U.S. Supreme Court decision in February 2026 that invalidated certain tariffs previously imposed under the International Emergency Economic Powers Act ("IEEPA"). Following the ruling...' (newer filing, 2026-07-31).
- Notes:
- Newer filing text appears truncated at 'We sell products for all three se' and older filing text appears truncated at 'We sell products for all three segments through our own sales force, independent distribu'; comparison is limited to the provided excerpt.
Risk Factors
- Added:
- Newer filing (2026-07-31) adds rows for April 1-30, 2026, May 1-31, 2026, and June 1-30, 2026 in the share repurchase table, including Second Quarter and Total figures.
- Newer filing (2026-07-31) states a total of 342,788 shares have been repurchased under the December 2025 program since its inception.
- Removed:
- Older filing (2026-04-30) included Exhibits 10.1, 10.2, and 10.3 (Form of Agreement for Restricted Stock Grant, Performance Share Unit Grant, and Stock Option Grant), which are not listed in the newer filing's exhibit table.
- Reworded:
- Newer filing (2026-07-31) states share repurchase activity is for the 'six months ended June 30, 2026'; older filing (2026-04-30) states it is for the 'three months ended March 31, 2026'.
- Newer filing (2026-07-31) states no directors or officers adopted, modified or terminated a Rule 10b5-1 trading arrangement during the fiscal quarter ended June 30, 2026; older filing (2026-04-30) states the same for the fiscal quarter ended March 31, 2026.
- In footnote (2), older filing (2026-04-30) describes the December 2025 program as 'a new stock repurchase program' and states 'This new stock repurchase program has no expiration date'; newer filing (2026-07-31) omits the word 'new' and states 'The stock repurchase program has no expiration date'.
- Newer filing (2026-07-31) signature date is July 31, 2026; older filing (2026-04-30) signature date is April 30, 2026.
- Notes:
- The provided texts appear to be the full Item 1A sections from each filing plus adjacent sections, but only the Risk Factors section was explicitly requested for comparison; changes to Items 2, 5, 6, and signatures are included because they appeared in the source texts.
- The Risk Factors text itself (Item 1A) is identical between the two filings.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales are on record for BCPC — recent Form 4 activity was compensation-related (awards, option exercises, or tax withholding), not open-market buying or selling.
View full insider trading history → View SEC Form 3/4/5 filingsOnly open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
U.S. House trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 2 matched disclosures for BCPC from U.S. House Clerk Periodic Transaction Report filings.
U.S. House trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding BCPC as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 7,161,043
- Reported value $1,209,858,273
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 4 increased, 2 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about BCPC's institutional holders → See what each manager we track holds →
Short interest (FINRA)
BCPC had 620,041 shares of reported short interest as of the 2026-09-15 FINRA settlement date (delayed, bi-monthly; not real-time).
BCPC had 1.95% of its shares outstanding sold short as of the 2026-09-15 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 3.3 days to cover at the same settlement.
- Reported short interest (shares) 620,041
- Short interest (% of shares outstanding) 1.95%
- Prior settlement (shares) 554,840
- Reported change 11.75%
- Days to cover (reported) 3.3
Reported to FINRA as of the 2026-09-15 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- DSM-Firmenich
- Kerry Group (KRYAY)
- Ingredion (INGR)
- IFF (IFF)
- Kemin Industries
- Alltech
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare BCPC vs…
BALCHEM CORP is found in…
Frequently asked questions
What does BALCHEM CORP (BCPC) do?
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, pharmaceutical, animal health, and medical sterilization markets. The company operates through segments focused on human nutrition and health, animal nutrition and health, and specialty products, providing solutions such as microencapsulation, minerals, and gases.
What sector is BALCHEM CORP (BCPC) in?
BALCHEM CORP (BCPC) is classified in the Materials sector. Its industry is Specialty Chemicals / Specialty Ingredients. It trades on NASDAQ.
Does BCPC pay a dividend?
Yes — BALCHEM CORP (BCPC) pays a dividend, with an indicated yield of about 0.57% and at least 4 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-09-03). Informational only — not financial advice.
Who are BALCHEM CORP's (BCPC) competitors?
Notable peers of BALCHEM CORP (BCPC) include DSM-Firmenich, Kerry Group, Ingredion, IFF and Kemin Industries. This peer set is informational only — not financial advice.
Has there been recent U.S. House stock trading in BCPC?
Yes — we hold 2 matched STOCK Act disclosures for BCPC from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is BALCHEM CORP (BCPC) overbought or oversold right now?
BALCHEM CORP (BCPC) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 51, in the neutral middle (as of 2026-10-08). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on BCPC come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.